Altimmune (ALT) EBT Margin (QoQ) (2010 - 2025)

Altimmune (ALT) EBT Margin (QoQ) (2010 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Altimmune 7.96 Mn 7.96 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 60.29 Mn
Sep 30, 2025 6.26 Mn
Jun 30, 2025 -3.78 Mn
Mar 31, 2025 5.85 Mn
Dec 31, 2024 -670,000.00
Sep 30, 2024 3.59 Mn
Jun 30, 2024 -492,000.00
Mar 31, 2024 -40.24 Mn
Dec 31, 2023 -7.98 Mn
Sep 30, 2023 27.59 Mn
Jun 30, 2023 -18.55 Mn
Mar 31, 2023 -5.96 Mn
Dec 31, 2022 114.91 Mn
Sep 30, 2022 -93.40 Mn
Jun 30, 2022 -19.05 Mn
Mar 31, 2022 -6.10 Mn
Dec 31, 2021 2.10 Mn
Sep 30, 2021 -308,718.00
Jun 30, 2021 -1.63 Mn
Mar 31, 2021 -130,971.00